TAKEDA PHARMACEUTICALS CO. LTD. V. ZYDUS PHARMACEUTICALS USA, INC. , No. 13-1089 (Fed. Cir. 2012)
Annotate this Case
Download PDF
Case: 13-1089 Document: 9 Page: 1 Filed: 12/07/2012 NOTE: This order is nonprecedential. United States Court of Appeals for the Federal Circuit __________________________ TAKEDA PHARMACEUTICALS COMPANY LIMITED, TAKEDA PHARMACEUTICALS NORTH AMERICA, INC., TAKEDA PHARMACEUTICALS, LLC, TAKEDA PHARMACEUTICALS AMERICA, INC., AND ETHYPHARM, S.A., Plaintiffs-Appellees, v. ZYDUS PHARMACEUTICALS USA, INC. AND CADILA HEALTHCARE, LIMITED, Defendants-Appellants. __________________________ 2013-1089 __________________________ Appeal from the United States District Court for the District of New Jersey in case no. 10-CV-1723, Judge Joel A. Pisano. __________________________ ON MOTION __________________________ ORDER The appellants move to expedite briefing and argument. Upon consideration thereof, Case: 13-1089 Document: 9 Page: 2 Filed: 12/07/2012 TAKEDA PHARMACEUTICALS CO. V. ZYDUS PHARMACEUTICALS USA 2 IT IS ORDERED THAT: (1) The motion to expedite briefing is granted to the following extent: The appellants' opening brief is due December 17. The appellees' brief is due January 2, 2013. The appellants' reply brief and the joint appendix are due January 9, 2013. (2) Oral argument will be scheduled by subsequent order of the court. FOR THE COURT s8 /s/ Jan Horbaly Jan Horbaly Clerk
Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
